乳腺癌 非浸润性乳腺癌的临床试验
总计17334个结果
-
Taipei City Hospital完全的PRU(血小板反应单位) | APT(抗血小板治疗) | HOTPR(High on Treat Platelet Reactivity)台湾
-
Stanford UniversityNational Institutes of Health (NIH); University of California; Breast Cancer Research Foundation; California Breast Cancer Research Program主动,不招人
-
Stanford UniversityCalifornia Breast Cancer Research Program完全的沮丧 | 乳腺癌 | 压力 | 乳腺癌 非浸润性乳腺癌 | 乳腺癌 早期乳腺癌(1-3 期) | 乳腺癌 转移性乳腺癌美国
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Hoffmann-La Roche; Brigham and Women's Hospital终止
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.A终止
-
Dana-Farber Cancer InstitutePfizer完全的
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional Oncology Hospital,...未知
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阳性乳腺癌 | HER2 阴性乳腺癌 | 浸润性小叶乳腺癌 | 浸润性导管癌美国, 波多黎各
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead Sciences主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | HER2 阴性乳腺癌 | HR 阳性乳腺癌美国
-
Atossa Therapeutics, Inc.InClin招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC终止
-
Sindh Institute of Urology and Transplantation完全的
-
Emory UniversityNational Cancer Institute (NCI)招聘中
-
Massachusetts General HospitalGilead Sciences招聘中
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.撤销
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
NRG OncologyNational Cancer Institute (NCI)暂停
-
Jonsson Comprehensive Cancer CenterDaiichi Sankyo Co., Ltd.; Translational Research in Oncology-U.S招聘中浸润性乳腺癌 | II期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 激素受体阳性乳腺癌 | 早期乳腺癌 | III期乳腺癌美国
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense主动,不招人乳腺癌 | 乳腺癌,男性 | HER2阳性乳腺癌 | 浸润性乳腺癌 | II期乳腺癌 | 乳腺癌女性 | HER2阳性乳腺癌 | III期乳腺癌美国
-
University of Wisconsin, MadisonNational Center for Advancing Translational Sciences (NCATS)招聘中
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
NSABP Foundation IncGlaxoSmithKline未知
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.主动,不招人
-
City of Hope Medical CenterNational Cancer Institute (NCI)终止IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性乳腺癌 | 浸润性导管癌美国
-
Baylor Breast Care Center招聘中乳腺癌 | 乳腺肿瘤 | 三阴性乳腺癌 | 三阴性乳腺肿瘤 | HER2阳性乳腺癌 | 乳腺癌二期 | 乳腺癌女性 | 乳腺癌三期 | 雌激素受体阳性乳腺癌 | 激素受体阳性乳腺癌 | 侵袭性乳腺癌美国
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZeneca主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | BRIP1基因突变 | PALB2基因突变 | ATM基因突变 | CHEK2基因突变 | NBN基因突变 | RAD51基因突变 | 体细胞突变乳腺癌 (BRCA1) | 体细胞突变乳腺癌 (BRCA2)美国
-
University Medical Center GroningenMartini Hospital Groningen招聘中
-
Seoul National University HospitalMinistry of Health & Welfare, Korea招聘中
-
Istari Oncology, Inc.United States Department of Defense; Duke University完全的
-
Institut Claudius Regaud主动,不招人